A Scientific Advance In Studying Earlystage Lung Cancer | Latest News RSS Feed

A Scientific Advance In Studying Earlystage Lung Cancer - Latest News


A scientific advance in studying early-stage lung cancer

Lung cancer is the leading cancer killer in the US. It is often missed in its earlier stages, and while recent imaging advances have enabled earlier detection, there are still no targeted treatments ... read more

Add your link right here

Add your story here to improve SEO, search ranking and drive traffic to your website. Your link will be permanently featured right on this page. To add a link on diferent page, just visit the page you want to show your link and click "Add your link right here". You can use search form below to find the page. read more

New organoids facilitate faster study of early lung cancer, potential treatments

Lung cancer is the leading cancer killer in the U.S. It is often missed in its earlier stages, and while recent imaging advances ... "In this study, we were able to use early-stage samples from ... read more

Amgen drug shrinks tumors in lung cancer patients with KRAS gene mutation - study

An experimental Amgen Inc drug that targets a specific genetic mutation shrank tumors in 32% of advanced lung cancer patients and 7% of those with colon cancer, according to data from an early-stage ... read more

Looking for other news?


Researchers develop therapy that can detect lung cancer at early stage

The researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) have developed a diagnostic therapy for lung cancer that can detect the disease at an early stage paving the ... read more


Novel Diagnostic Therapy can Detect Lung Cancer at Early Stage

Experts may soon find a solution to detect lung cancer ... study are published in the journal scientific research. Prof. T. Govindaraju supervised the research from Jawaharlal Nehru Centre for ... read more

Lung cancer in non-smokers likely to respond differently to treatment

Image: Lung cancer cells. Credit: Anne Weston, CC BY-NC 4.0 Lung cancer in non-smokers is a diverse and distinct disease from that in smokers, and is likely to respond differently to targeted ... read more

New study shows SHP2 inhibition overcomes multiple therapeutic-resistance mechanisms in lung cancer

New preclinical research from The University of Texas MD Anderson Cancer Center and BridgeBio Pharma, Inc. affiliate Navire Pharma, Inc., finds that the novel SHP2 inhibitor IACS-13909 is able to ... read more

Janssen Presents Findings from Global, Multi-Centre Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer

FOR EU TRADE AND MEDICAL MEDIA ONLY. NOT FOR DISTRIBUTION IN BENELUX. The Janssen Pharmaceutical Companies of Johnson & Johnson announced yesterda ... read more

Study: A scientific advance in studying early-stage lung cancer

Lung cancer is the leading cancer killer in the U.S. It is often missed in its earlier stages, and while recent imaging advances have enabled earlier detection, there are still no targeted treatments ... read more

Diagnostic therapy to detect lung cancer at early stage developed

The researchers from Jawaharlal Nehru Centre for Advanced Scientific Research (JNCASR) have developed a diagnostic therapy for lung cancer that can detect the disease at an early stage paving the ... read more

New study from MD Anderson and BridgeBio's Navire Pharma shows SHP2 inhibition overcomes multiple therapeutic-resistance mechanisms in lung cancer

New preclinical research from MD Anderson and Navire finds a novel drug targeting SHP2 can overcome multiple paths of therapeutic resistance in lung cancer. Navire will launch a clinical trial of SHP2 ... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us